{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:21:43Z","timestamp":1790644903806,"version":"4.1.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Defining the clinical relevance of donor-specific HLA antibodies (DSA) detection by Luminex single-antigen (LSA) flow beads assay is critical in monitoring posttransplant outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>Sera of kidney transplanted patients were tested by LSA1 and LSA2 with One Lambda Labscreen (test 1) and Immucor Lifecodes (test 2), at the time of a graft biopsy. The first group (G1, n = 50) had a biopsy highly suggestive of humoral rejection, and the second (G2, n = 50) had no criteria of rejection. Positivity criteria for DSA was mean fluorescence intensity greater than 500 for test 1, whereas specificity assignation respected the provider\u2019s recommendations for test 2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>In G1, we identified at least 1 DSA in 44 patients with test 1, and in 39 patients with test 2. In G2, test 1 identified at least 1 DSA in 16 (32%) patients and test 2 in 7 (14%) patients. Sensitivity and specificity for antibody-mediated rejection diagnosis was 88% and 68%, respectively, with One Lambda, and 78% and 86%, respectively, with Immucor. Correlation and agreement were found in class I and II between intensity parameters of the 2 manufacturers. The use of the sum of the intensity of DSA improved the sensitivity and specificity of the 2 tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>We report the first comparative study of the 2 Luminex assays available for detecting DSA in the postkidney transplant setting. Although there is a good correlation and reliability between the 2 assays, significant differences exist. Positivity criteria for DSA determination differ and interpretation should take these specificities into account.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000002351","type":"journal-article","created":{"date-parts":[[2018,6,30]],"date-time":"2018-06-30T02:10:51Z","timestamp":1530324651000},"page":"597-603","source":"Crossref","is-referenced-by-count":36,"title":["Comparison of Two Luminex Single-antigen Bead Flow Cytometry Assays for Detection of Donor-specific Antibodies After Renal Transplantation"],"prefix":"10.1097","volume":"103","author":[{"given":"Dominique","family":"Bertrand","sequence":"first","affiliation":[{"name":"Department of Nephrology and Transplantation, Rouen University Hospital, Rouen, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Farce","sequence":"additional","affiliation":[{"name":"Laboratory of Histocompatibility, EFS Normandie, Rouen, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Laurent","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Transplantation, Rouen University Hospital, Rouen, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Hamelin","sequence":"additional","affiliation":[{"name":"Laboratory of Histocompatibility, EFS Normandie, Rouen, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Fran\u00e7ois","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Pathology, Rouen University Hospital, Rouen, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Guerrot","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Transplantation, Rouen University Hospital, Rouen, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Etienne","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Transplantation, Rouen University Hospital, Rouen, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Hau","sequence":"additional","affiliation":[{"name":"Laboratory of Histocompatibility, EFS Normandie, Rouen, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1600-6143.2010.03340.x","article-title":"Calculated PRA: initial results show benefits for sensitized patients and a reduction in positive crossmatches.","volume":"11","author":"Cecka","year":"2011","journal-title":"Am J Transplant"},{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1600-6143.2011.03452.x","article-title":"Calculated PRA: a process whose time has come or \u2018D\u00e9j\u00e0 vu\u2019 all over again?","volume":"11","author":"Bray","year":"2011","journal-title":"Am J Transplant"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1600-6143.2009.02927.x","article-title":"Calculated PRA, (CPRA): the new measure of sensitization for transplant candidates.","volume":"10","author":"Cecka","year":"2010","journal-title":"Am J Transplant"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant.","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.humimm.2011.07.001","article-title":"Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads.","volume":"72","author":"Chen","year":"2011","journal-title":"Hum Immunol"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/lt.23451","article-title":"Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with chronic rejection and graft loss after liver transplantation.","volume":"18","author":"Kaneku","year":"2012","journal-title":"Liver Transplant"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3343\/alm.2015.35.3.321","article-title":"Interlaboratory comparison of the results of lifecodes LSA class I and class II single antigen kits for human leukocyte antigen antibody detection.","volume":"35","author":"Oh","year":"2015","journal-title":"Ann Lab Med"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/ajt.12287","article-title":"Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA.","volume":"13","author":"Reed","year":"2013","journal-title":"Am J Transplant"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/ajt.14107","article-title":"The Banff 2015 Kidney Meeting Report: current challenges in rejection classification and prospects for adopting molecular pathology.","volume":"17","author":"Loupy","year":"2017","journal-title":"Am J Transplant"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1600-6143.2012.04325.x","article-title":"Microcirculation inflammation associates with outcome in renal transplant patients with de novo donor-specific antibodies.","volume":"13","author":"de Kort","year":"2013","journal-title":"Am J Transplant"},{"key":"R12-20231002","first-page":"420:86","article-title":"Intraclass correlations: uses in assessing rater reliability.","author":"Shrout","year":"1979","journal-title":"Psychol Bull"},{"key":"R13-20231002","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/TP.0000000000000191","article-title":"Pretransplant immunologic risk assessment of kidney transplant recipients with donor-specific anti-human leukocyte antigen antibodies.","volume":"98","author":"Marfo","year":"2014","journal-title":"Transplantation"},{"key":"R14-20231002","first-page":"390","article-title":"Cytotoxic antibodies\u2014valuable prognostic factor for long term kidney allograft survival.","volume":"3","author":"Moise","year":"2010","journal-title":"J Med Life"},{"key":"R15-20231002","first-page":"473","article-title":"Comparative evaluation of ELISA and Luminex panel reactive antibody assays for HLA alloantibody screening.","volume":"29","author":"Jung","year":"2009","journal-title":"Korean J Lab Med"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1681\/ASN.2013101144","article-title":"Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss.","volume":"26","author":"Sicard","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/ajt.14201","article-title":"Prozone effect can be specific to single antigen bead kit manufacturers.","volume":"17","author":"Battle","year":"2017","journal-title":"Am J Transplant"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/ajt.12332","article-title":"Influence of test technique on sensitization status of patients on the kidney transplant waiting list.","volume":"13","author":"Gombos","year":"2013","journal-title":"Am J Transplant"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/TP.0b013e3181e36e08","article-title":"Donor-specific antibody levels and three generations of crossmatches to predict antibody-mediated rejection in kidney transplantation.","volume":"90","author":"Riethm\u00fcller","year":"2010","journal-title":"Transplantation"},{"key":"R20-20231002","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/ajt.14229","article-title":"The road to HLA antibody evaluation: do not rely on MFI.","volume":"17","author":"Sullivan","year":"2017","journal-title":"Am J Transplant"},{"key":"R21-20231002","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1111\/ajt.13295","article-title":"Assessing antibody strength: comparison of MFI, C1q, and titer Information.","volume":"15","author":"Tambur","year":"2015","journal-title":"Am J Transplant"},{"key":"R22-20231002","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1681\/ASN.2016030368","article-title":"Value of donor-specific anti-HLA antibody monitoring and characterization for risk stratification of kidney allograft loss.","volume":"28","author":"Viglietti","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R23-20231002","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1681\/ASN.2014111120","article-title":"IgG donor-specific anti-human HLA antibody subclasses and kidney allograft antibody-mediated injury.","volume":"27","author":"Lefaucheur","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R24-20231002","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1097\/TXD.0000000000000734","article-title":"Comparative assessment of anti-HLA antibodies using two commercially available luminex-based assays.","volume":"3","author":"Clerkin","year":"2017","journal-title":"Transplant Direct"},{"key":"R25-20231002","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/TP.0b013e31822872dd","article-title":"HLA antibody specification using single-antigen beads\u2014a technical solution for the prozone effect.","volume":"92","author":"Schnaidt","year":"2011","journal-title":"Transplantation"},{"key":"R27-20231002","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.humimm.2011.02.012","article-title":"Donor-specific antibody against denatured HLA-A1: clinically nonsignificant?","volume":"72","author":"Pereira","year":"2011","journal-title":"Hum Immunol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007890-201903000-00028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T01:25:43Z","timestamp":1696209943000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201903000-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002351","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}